Sanders Calls on Trump to Rescind Pharma Giveaway of Potential Coronavirus Treatment
WASHINGTON, March 24—Reacting to the decision by the Trump Administration’s FDA to grant Gilead Sciences a seven-year monopoly for antiviral medication remdesivir for potential treatment of the coronavirus, Sen. Bernie Sanders (I-Vt.) issued the following statement: “It is truly outrageous that after taxpayers put tens of millions of dollars into developing remdesivir, Trump’s FDA is exploiting a law reserved for